Virus glycosylation: role in virulence and immune interactions

Trends in Microbiology

Volumn 15, Issue 5, 2007, Pages 211-218

  Vigerust, David J ^a   Shepherd, Virginia L ^a,b  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Department of Veteran Affairs ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE; HYDROXYCHLOROQUINE; VIRUS GLYCOPROTEIN;

GLYCOSYLATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNITY; INFLUENZA VIRUS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; VIRUS VIRULENCE; WEST NILE FLAVIVIRUS;

GLYCOPROTEINS; GLYCOSYLATION; HIV-1; INFLUENZA A VIRUS; MODELS, BIOLOGICAL; RECEPTORS, IMMUNOLOGIC; VIRAL PROTEINS; VIRULENCE; VIRUSES; WEST NILE VIRUS;

SARS CORONAVIRUS;

EID: 34247530859     PISSN: 0966842X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tim.2007.03.003     Document Type: Review

References (80)

1. Land A., and Braakman I. Folding of the human immunodeficiency virus type 1 envelope glycoprotein in the endoplasmic reticulum. Biochimie 83 (2001) 783-790
2. Slater-Handshy T., et al. HCV E2 glycoprotein: mutagenesis of N-linked glycosylation sites and its effects on E2 expression and processing. Virology 319 (2004) 36-48
3. Meunier J.C., et al. Analysis of the glycosylation sites of hepatitis C virus (HCV) glycoprotein E1 and the influence of E1 glycans on the formation of the HCV glycoprotein complex. J. Gen. Virol. 80 (1999) 887-896
4. Wagner R., et al. Interdependence of hemagglutinin glycosylation and neuraminidase as regulators of influenza virus growth: a study by reverse genetics. J. Virol. 74 (2000) 6316-6323
5. Klenk H.D., et al. Importance of hemagglutinin glycosylation for the biological functions of influenza virus. Virus Res. 82 (2002) 73-75
6. Baigent S.J., and McCauley J.W. Glycosylation of haemagglutinin and stalk-length of neuraminidase combine to regulate the growth of avian influenza viruses in tissue culture. Virus Res. 79 (2001) 177-185
7. Tsuchiya E., et al. Role of overlapping glycosylation sequons in antigenic properties, intracellular transport and biological activities of influenza A/H2N2 virus haemagglutinin. J. Gen. Virol. 83 (2002) 3067-3074
8. Tsuchiya E., et al. Effect of addition of new oligosaccharide chains to the globular head of influenza A/H2N2 virus haemagglutinin on the intracellular transport and biological activities of the molecule. J. Gen. Virol. 83 (2002) 1137-1146
9. Abe Y., et al. Effect of the addition of oligosaccharides on the biological activities and antigenicity of influenza A/H3N2 virus hemagglutinin. J. Virol. 78 (2004) 9605-9611
10. Kaverin N.V., et al. Structure of antigenic sites on the haemagglutinin molecule of H5 avian influenza virus and phenotypic variation of escape mutants. J. Gen. Virol. 83 (2002) 2497-2505
11. Daniels R., et al. N-linked glycans direct the cotranslational folding pathway of influenza hemagglutinin. Mol. Cell 11 (2003) 79-90
12. Keil W., et al. Carbohydrates of influenza virus. V. Oligosaccharides attached to individual glycosylation sites of the hemagglutinin of fowl plague virus. Virology 133 (1984) 77-91
13. Skehel J.J., and Wiley D.C. Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu. Rev. Biochem. 69 (2000) 531-569
14. Hoffmann E., et al. Eight-plasmid system for rapid generation of influenza virus vaccines. Vaccine 20 (2002) 3165-3170
15. Deshpande K.L., et al. Glycosylation affects cleavage of an H5N2 influenza virus hemagglutinin and regulates virulence. Proc. Natl. Acad. Sci. U. S. A. 84 (1987) 36-40
16. Zambon M.C. Epidemiology and pathogenesis of influenza. J. Antimicrob. Chemother. 44 Suppl. B (1999) 3-9
17. Fenouillet E., et al. Role of N-linked glycans of envelope glycoproteins in infectivity of human immunodeficiency virus type 1. J. Virol. 64 (1990) 2841-2848
18. Montefiori D.C., et al. Role of protein N-glycosylation in pathogenesis of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. U. S. A. 85 (1988) 9248-9252
19. Korber B., et al. Evolutionary and immunological implications of contemporary HIV-1 variation. Br. Med. Bull. 58 (2001) 19-42
20. Sagar M., et al. Human immunodeficiency virus type 1 V1-V2 envelope loop sequences expand and add glycosylation sites over the course of infection, and these modifications affect antibody neutralization sensitivity. J. Virol. 80 (2006) 9586-9598
21. Wolk T., and Schreiber M. N-Glycans in the gp120 V1/V2 domain of the HIV-1 strain NL4-3 are indispensable for viral infectivity and resistance against antibody neutralization. Med. Microbiol. Immunol. (Berl.) 195 (2006) 165-172
22. Sanders R.W., et al. The mannose-dependent epitope for neutralizing antibody 2G12 on human immunodeficiency virus type 1 glycoprotein gp120. J. Virol. 76 (2002) 7293-7305
23. Calarese D.A., et al. Dissection of the carbohydrate specificity of the broadly neutralizing anti-HIV-1 antibody 2G12. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 13372-13377
24. Calarese D.A., et al. Antibody domain exchange is an immunological solution to carbohydrate cluster recognition. Science 300 (2003) 2065-2071
25. Wei X., et al. Antibody neutralization and escape by HIV-1. Nature 422 (2003) 307-312
26. Frost S.D., et al. Neutralizing antibody responses drive the evolution of human immunodeficiency virus type 1 envelope during recent HIV infection. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 18514-18519
27. Poon A.F., et al. Evolutionary interactions between N-linked glycosylation sites in the HIV-1 envelope. PLoS Comput. Biol. 3 (2007) e11
28. Romanelli F., et al. Chloroquine and hydroxychloroquine as inhibitors of human immunodeficiency virus (HIV-1) activity. Curr. Pharm. Des. 10 (2004) 2643-2648
29. Boelaert J.R., et al. Chloroquine exerts an additive in vitro anti-HIV type 1 effect when associated with didanosine and hydroxyurea. AIDS Res. Hum. Retroviruses 15 (1999) 1241-1247
30. Sperber K., et al. Hydroxychloroquine treatment of patients with human immunodeficiency virus type 1. Clin. Ther. 17 (1995) 622-636
31. Paton N.I., and Aboulhab J. Hydroxychloroquine, hydroxyurea and didanosine as initial therapy for HIV-infected patients with low viral load: safety, efficacy and resistance profile after 144 weeks. HIV Med. 6 (2005) 13-20
32. Savarino A., et al. New insights into the antiviral effects of chloroquine. Lancet Infect. Dis. 6 (2006) 67-69
33. Shirato K., et al. Viral envelope protein glycosylation is a molecular determinant of the neuroinvasiveness of the New York strain of West Nile virus. J. Gen. Virol. 85 (2004) 3637-3645
34. Scherret J.H., et al. Biological significance of glycosylation of the envelope protein of Kunjin virus. Ann. N. Y. Acad. Sci. 951 (2001) 361-363
35. Beasley D.W., et al. Envelope protein glycosylation status influences mouse neuroinvasion phenotype of genetic lineage 1 West Nile virus strains. J. Virol. 79 (2005) 8339-8347
36. Lad V.J., et al. Effect of tunicamycin on expression of epitopes on Japanese encephalitis virus glycoprotein E in porcine kidney cells. Acta Virol. 44 (2000) 359-364
37. Hanna S.L., et al. N-linked glycosylation of West Nile virus envelope proteins influences particle assembly and infectivity. J. Virol. 79 (2005) 13262-13274
38. Beyene A., et al. Influence of N-linked glycans on intracellular transport of hepatitis C virus E1 chimeric glycoprotein and its role in pseudotype virus infectivity. Virology 324 (2004) 273-285
39. Goffard A., et al. Role of N-linked glycans in the functions of hepatitis C virus envelope glycoproteins. J. Virol. 79 (2005) 8400-8409
40. Goffard A., and Dubuisson J. Glycosylation of hepatitis C virus envelope proteins. Biochimie 85 (2003) 295-301
41. Eichler R., et al. The role of single N-glycans in proteolytic processing and cell surface transport of the Lassa virus glycoprotein GP-C. Virol. J. 3 (2006) 41
42. Aguilar H.C., et al. N-glycans on Nipah virus fusion protein protect against neutralization but reduce membrane fusion and viral entry. J. Virol. 80 (2006) 4878-4889
43. Melanson V.R., and Iorio R.M. Addition of N-glycans in the stalk of the Newcastle disease virus HN protein blocks its interaction with the F protein and prevents fusion. J. Virol. 80 (2006) 623-633
44. Shi X., et al. Role of N-linked glycans on bunyamwera virus glycoproteins in intracellular trafficking, protein folding, and virus infectivity. J. Virol. 79 (2005) 13725-13734
45. Moll M., et al. Influence of N-glycans on processing and biological activity of the nipah virus fusion protein. J. Virol. 78 (2004) 7274-7278
46. Lin G., et al. Differential N-linked glycosylation of human immunodeficiency virus and Ebola virus envelope glycoproteins modulates interactions with DC-SIGN and DC-SIGNR. J. Virol. 77 (2003) 1337-1346
47. Bossart K.N., et al. Receptor binding, fusion inhibition, and induction of cross-reactive neutralizing antibodies by a soluble G glycoprotein of Hendra virus. J. Virol. 79 (2005) 6690-6702
48. Oostra M., et al. Glycosylation of the severe acute respiratory syndrome coronavirus triple-spanning membrane proteins 3a and M. J. Virol. 80 (2006) 2326-2336
49. Schowalter R.M., et al. Characterization of human metapneumovirus F protein-promoted membrane fusion: critical roles for proteolytic processing and low pH. J. Virol. 80 (2006) 10931-10941
50. Cambi A., et al. Microdomains of the C-type lectin DC-SIGN are portals for virus entry into dendritic cells. J. Cell Biol. 164 (2004) 145-155
51. Cambi A., and Figdor C.G. Dual function of C-type lectin-like receptors in the immune system. Curr. Opin. Cell Biol. 15 (2003) 539-546
52. Reading P.C., et al. Involvement of the mannose receptor in infection of macrophages by influenza virus. J. Virol. 74 (2000) 5190-5197
53. Nguyen D.G., and Hildreth J.E. Involvement of macrophage mannose receptor in the binding and transmission of HIV by macrophages. Eur. J. Immunol. 33 (2003) 483-493
54. Vigerust D.J., et al. HIV-1 Nef mediates post-translational down-regulation and redistribution of the mannose receptor. J. Leukoc. Biol. 77 (2005) 522-534
55. Lozach P.Y., et al. DC-SIGN and L-SIGN are high affinity binding receptors for hepatitis C virus glycoprotein E2. J. Biol. Chem. 278 (2003) 20358-20366
56. Davis C.W., et al. The location of asparagine-linked glycans on West Nile virions controls their interactions with CD209 (DC-SIGN). J. Biol. Chem. 281 (2006) 37183-37194
57. Davis C.W., et al. West Nile virus discriminates between DC-SIGN and DC-SIGNR for cellular attachment and infection. J. Virol. 80 (2006) 1290-1301
58. Marzi A., et al. The signal peptide of the ebolavirus glycoprotein influences interaction with the cellular lectins DC-SIGN and DC-SIGNR. J. Virol. 80 (2006) 6305-6317
59. Marzi A., et al. DC-SIGN and DC-SIGNR interact with the glycoprotein of Marburg virus and the S protein of severe acute respiratory syndrome coronavirus. J. Virol. 78 (2004) 12090-12095
60. Turville S.G., et al. HIV gp120 receptors on human dendritic cells. Blood 98 (2001) 2482-2488
61. Liu Y., et al. CD4-independent infection of astrocytes by human immunodeficiency virus type 1: requirement for the human mannose receptor. J. Virol. 78 (2004) 4120-4133
62. Gramberg T., et al. LSECtin interacts with filovirus glycoproteins and the spike protein of SARS coronavirus. Virology 340 (2005) 224-236
63. Reading P.C., et al. Collectin-mediated antiviral host defense of the lung: evidence from influenza virus infection of mice. J. Virol. 71 (1997) 8204-8212
64. Thielens N.M., et al. Interaction of C1q and mannan-binding lectin with viruses. Immunobiology 205 (2002) 563-574
65. White M.R., et al. Enhanced antiviral and opsonic activity of a human mannose-binding lectin and surfactant protein D chimera. J. Immunol. 165 (2000) 2108-2115
66. Hartshorn K.L., et al. Evidence for a protective role of pulmonary surfactant protein D (SP-D) against influenza A viruses. J. Clin. Invest. 94 (1994) 311-319
67. Meschi J., et al. Surfactant protein D binds to human immunodeficiency virus (HIV) envelope protein gp120 and inhibits HIV replication. J. Gen. Virol. 86 (2005) 3097-3107
68. Witvrouw M., et al. Resistance of human immunodeficiency virus type 1 to the high-mannose binding agents cyanovirin N and concanavalin A. J. Virol. 79 (2005) 7777-7784
69. Williams Jr. D.C., et al. Crystal structures of the HIV-1 inhibitory cyanobacterial protein MVL free and bound to Man3GlcNAc2: structural basis for specificity and high-affinity binding to the core pentasaccharide from n-linked oligomannoside. J. Biol. Chem. 280 (2005) 29269-29276
70. Balzarini J., et al. Carbohydrate-binding agents efficiently prevent dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin (DC-SIGN)-directed HIV-1 transmission to T lymphocytes. Mol. Pharmacol. 71 (2007) 3-11
71. O'Keefe B.R., et al. Potent anti-influenza activity of cyanovirin-N and interactions with viral hemagglutinin. Antimicrob. Agents Chemother. 47 (2003) 2518-2525
72. Hawgood S., et al. Pulmonary collectins modulate strain-specific influenza a virus infection and host responses. J. Virol. 78 (2004) 8565-8572
73. LeVine A.M., et al. Surfactant protein D enhances clearance of influenza A virus from the lung in vivo. J. Immunol. 167 (2001) 5868-5873
74. Hartshorn K.L., et al. Salivary agglutinin and lung scavenger receptor cysteine-rich glycoprotein 340 have broad anti-influenza activities and interactions with surfactant protein D that vary according to donor source and sialylation. Biochem. J. 393 (2006) 545-553
75. White M.R., et al. Cooperative anti-influenza activities of respiratory innate immune proteins and neuraminidase inhibitor. Am. J. Physiol. Lung Cell. Mol. Physiol. 288 (2005) L831-L840
76. Ji X., et al. Mannose binding lectin (MBL) and HIV. Mol. Immunol. 42 (2005) 145-152
77. Hart M.L., et al. High mannose glycans and sialic acid on gp120 regulate binding of mannose-binding lectin (MBL) to HIV type 1. AIDS Res. Hum. Retroviruses 18 (2002) 1311-1317
78. Geijtenbeek T.B., et al. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell 100 (2000) 587-597
79. Wang Q.C., et al. DC-SIGN: binding receptors for hepatitis C virus. Chin. Med. J. (Engl.) 117 (2004) 1395-1400
80. Li J., et al. The glycosylation site in the envelope protein of West Nile virus (Sarafend) plays an important role in replication and maturation processes. J. Gen. Virol. 87 (2006) 613-622